Creative and Integrated Pharma Lifecycle Management Strategies “Remain Vital”

April 21, 2017

The pharmaceutical industry is seeking new business models, specifically holistic methods or strategies that can accelerate new product development or lengthen the lifecycle of products more effectively. This is because of a range of challenges that the industry faces, such as pricing pressures, stringent regulatory policies, and declining R&D productivity.

The pharmaceutical industry is seeking new business models, specifically holistic methods or strategies that can accelerate new product development or lengthen the lifecycle of products more effectively. This is because of a range of challenges that the industry faces, such as pricing pressures, stringent regulatory policies, and declining R&D productivity.

According to a new report by GBI Research, the problems facing the industry leave pharma companies exposed to generic and biosimilar competition, which hits a substantial percentage of sales and market share within a short period of time and can see companies risk losing up to 90% of the revenue from some of their biggest products.